stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Xenon Pharmaceuticals IncXENE
$38.793.11%1.17

Xenon Pharmaceuticals Inc (XENE)

Date: 2026-11-03 16:00O: 38.04H: 39.00L: 37.78C: 38.78Vol: 449.7k
Schlusskurs vom Vortag:
$37.62
Offen:
$38.04
24-Stunden-Volumen:
456,563
Relatives Volumen:
0.35
Marktkapitalisierung:
$3.76B
Einnahmen:
$7.50M
Nettoeinkommen (Verlust:
-$383.17M
KGV:
-
EPS:
-$4.70
Netto-Cashflow:
-$307.84M
1W Leistung:
+7.72%
1M Leistung:
+2.03%
6M Leistung:
-30.89%
1Y Leistung:
-5.67%
1-Tages-Spanne:
$37.78$39.00
1-Wochen-Bereich:
$35.37$38.35
52-Wochen-Spanne:
$33.38$72.66

Xenon Pharmaceuticals Inc Aktie (XENE) Unternehmensprofil

Firmenname
Xenon Pharmaceuticals Inc
Telefon
(604) 484-3300
Adresse
200 - 3650 GILMORE WAY, BURNABY, Canada
Mitarbeiter
370
X
-
Nächster Verdiensttermin
null
Neueste SEC-Einreichungen
SEC
XENE-Diskussionen auf X
X

 

Marktkapitalisierung

 

Umsatz

 

Nettogewinn

 

Free Cashflow

 

ENV

 

Xenon Pharmaceuticals Inc Aktie (XENE) Hochstufungen & Herabstufungen

DatumAktionAnalytikerRatingänderung
2026-10-06ResumedGuggenheimBuy
2026-09-18HerabstufungDeutsche BankBuy → Hold
2026-02-24EingeleitetWolfe ResearchOutperform
2025-09-03ResumedWells FargoOverweight

Finanzdaten der Xenon Pharmaceuticals Inc-Aktie (XENE)

ZeitraumTrendFY 2025FY 2024FY 2023FY 2022FY 2021
Enddatum des Zeitraums2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)7.50-0.009.4318.44
Research and development USD (M)300.94210.39167.51105.7775.46
Operating expenses USD (M)380.57279.30214.05138.5897.43
Operating income USD (M)-373.07-279.30-214.05-129.14-78.99
Income before tax USD (M)-344.89-238.42-182.69-125.26-78.89
Income tax expense USD (M)1.02-4.09-0.290.12-0.01
Net income USD (M)-345.91-234.33-182.39-125.37-78.88
Basic EPS USD/shares-4.36-3.01-2.73-2.06-
Diluted EPS USD/shares-4.36-3.01-2.73-2.06-
Basic weighted shares shares (M)79.2577.8966.8960.54-
Diluted weighted shares shares (M)79.2577.8966.8960.54-

Xenon Pharmaceuticals Inc-Aktie (XENE) Insiderhandel

  • Chief Financial Officer
    Transaktion
    Buy
    Kosten
    $37.32
    #Aktien
    15,000
    Wert ($)
    559,740
    #Aktien Gesamt
    15,000
  • MORTIMER IANSep 30 '26
    PRESIDENT & CEO
    Transaktion
    Buy
    Kosten
    $37.38
    #Aktien
    30,000
    Wert ($)
    1,121,400
    #Aktien Gesamt
    49,923
  • Svoronos DawnSep 01 '26
    Director
    Transaktion
    Option Exercise
    Kosten
    $8.15
    #Aktien
    5,144
    Wert ($)
    41,924
    #Aktien Gesamt
    31,373
  • Officer
    Transaktion
    Proposed Sale
    Kosten
    $61.93
    #Aktien
    7,068
    Wert ($)
    437,721
    #Aktien Gesamt
    0
  • Chief Medical Officer
    Transaktion
    Sale
    Kosten
    $60.25
    #Aktien
    7,068
    Wert ($)
    425,829
    #Aktien Gesamt
    2
  • GANNON STEVENAug 11 '26
    Director
    Transaktion
    Sale
    Kosten
    $64.06
    #Aktien
    10,000
    Wert ($)
    640,550
    #Aktien Gesamt
    1,870
  • STEVEN GANNONAug 11 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $64.06
    #Aktien
    10,000
    Wert ($)
    640,553
    #Aktien Gesamt
    0
  • GARY PATOUJun 05 '26
    Director
    Transaktion
    Proposed Sale
    Kosten
    $52.99
    #Aktien
    1,322
    Wert ($)
    70,053
    #Aktien Gesamt
    0
  • PATOU GARYJun 05 '26
    Director
    Transaktion
    Sale
    Kosten
    $53.14
    #Aktien
    1,322
    Wert ($)
    70,251
    #Aktien Gesamt
    24,896
  • Cannon GillianJun 05 '26
    Director
    Transaktion
    Sale
    Kosten
    $53.14
    #Aktien
    1,190
    Wert ($)
    63,237
    #Aktien Gesamt
    1,455
InsiderhandelBeziehungDatumTransaktionKosten#AktienWert ($)#Aktien Gesamt
Kelly Thomas PatrickChief Financial OfficerSep 30 '26Buy$37.3215,000559,74015,000
MORTIMER IANPRESIDENT & CEOSep 30 '26Buy$37.3830,0001,121,40049,923
Svoronos DawnDirectorSep 01 '26Option Exercise$8.155,14441,92431,373
CHRISTOPHER KENNEYOfficerAug 28 '26Proposed Sale$61.937,068437,7210
KENNEY CHRISTOPHER JOHNChief Medical OfficerAug 28 '26Sale$60.257,068425,8292
GANNON STEVENDirectorAug 11 '26Sale$64.0610,000640,5501,870
STEVEN GANNONDirectorAug 11 '26Proposed Sale$64.0610,000640,5530
GARY PATOUDirectorJun 05 '26Proposed Sale$52.991,32270,0530
PATOU GARYDirectorJun 05 '26Sale$53.141,32270,25124,896
Cannon GillianDirectorJun 05 '26Sale$53.141,19063,2371,455

Xenon Pharmaceuticals Inc Aktie (XENE) Neueste Nachrichten

Oct 25, 2026
Oct 25, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 20, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 12, 2026
Oct 12, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 10, 2026
Oct 10, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 09, 2026
Oct 07, 2026
Oct 07, 2026
Oct 07, 2026
Oct 07, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 06, 2026
Oct 03, 2026
Oct 03, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 24, 2026
Sep 24, 2026

Ähnlich wie XENE